Insider Transactions in Q1 2021 at Inhibrx, Inc. (INBX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2021
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,000
-0.66%
|
$323,000
$19.02 P/Share
|
|
Feb 17
2021
|
Klaus W. Wagner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,559
-8.33%
|
$488,975
$25.29 P/Share
|
|
Feb 16
2021
|
Klaus W. Wagner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
156,474
-40.0%
|
$3,755,376
$24.32 P/Share
|
|
Feb 16
2021
|
Brendan P. Eckelman Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,000
-0.66%
|
$425,000
$25.9 P/Share
|